In addition to a working on a new allergy drug--one that directly targets B-cells carrying IgE on the surface which he hopes can complement Xolair--and studying the mechanisms of anti-IgE, he is researching ways to improve antibody engineering techniques. And development of a new drug for lymphatic cancer is in progress.
除了治療過敏的新藥物（直接以表面帶有 IgE 的 B 細胞為標的，希望能與「索雷爾」相輔相成）、Anti-IgE 藥理機制研究外，改善抗體工程技術，抗淋巴癌等新藥的研發，也在積極進行中。